A meta-analysis of randomized, controlled trials compared the use of benzodiazepines alone or in combination with antipsychotic or antihistamine medications in patients experiencing acute psychotic illness.
Exploring Safe and Effective Treatments for Bipolar Depression: Transcranial Direct Current StimulationJanuary 22, 2018
Transcranial direct current stimulation may be an effective add-on treatment for bipolar depression.
Twelve antipsychotics, including olanzapine, ziprasidone, and lurasidone, were examined in a meta-analysis.
Outcomes of long-term CBT in community settings were previously uncertain.
Researchers sought to examine the most efficacious treatment for clinical remission in adults with schizophrenia.
Treating acute pain before it develops into chronic pain may be the key to preventing chronic pain from arising in the first place.
The DEA's plan to list kratom as a Schedule I controlled substance would make researching the possible opioid substitute much more difficult.
CDC rank alcohol-attributable mortality as the third leading cause of preventable death in the United States.
One topic of criticism is the relative dearth of scientific evidence regarding the efficacy of 12-step programs.
Approximately 80% of depressive episodes have their onset during the first six months following traumatic brain injury.
Interaction of Proline and COMT Genotype Influences Negative Symptoms in Schizophrenia & Bipolar DisorderSeptember 27, 2016
The authors explored whether valproate (VPA) treatment effects vary by catechol-O-methyltransferase (COMT) genotype.
Dr. Roger McIntyre suggests that the clinical relevance of cognitive dysfunction for any individual patient can only be adjudicated on a case-by-case basis.
Converting just 1 meeting per week to a walking meeting can increase on-the-job activity levels for white-collar workers.
Clinical trials in humans are scheduled to begin later this year.
CDC researchers recommend behavioral modification therapy as treatment for ADHD in children between 2 and 5 years of age.
Poorly managed treatment-resistant schizophrenia has a significant personal and economic impact, with unfavorable long-term outcomes.
Antidepressants were found to be more effective with the concomitant use of nutritional supplements.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- The Challenges of Identifying Biomarkers of Psychiatric Illness
- FDA Approves Powerful New Opioid Despite Criticisms
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- FDA to Ban Most Flavored Electronic Cigarettes
- Predictors of CBT Outcomes Identified in Youths With Anxiety Disorders
- Happy Childhood Memories Associated With Better Health
- FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data
- Heart Rate Variability Predicts Treatment Response in Anxious Depression